A Study of GZR18 Injection in Chinese Patients With Type 2 Diabetes Mellitus
Status:
ACTIVE_NOT_RECRUITING
Trial end date:
2024-07-20
Target enrollment:
Participant gender:
Summary
This study was a multicenter, randomized, parallel and controlled study in adult patients with T2DM to evaluate the efficacy, safety (including immunogenicity) and pharmacokinetics of GZR18 injection in adult patients with T2DM.